PHR Phreesia Inc
Price (delayed)
$24.75
Market cap
$1.45B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.02
Enterprise value
$1.39B
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our
Highlights
PHR's EPS has surged by 59% year-on-year and by 30% since the previous quarter
Phreesia's net income has soared by 57% YoY and by 29% from the previous quarter
The debt is up by 49% year-on-year but it has declined by 15% since the previous quarter
Key stats
What are the main financial stats of PHR
Market
Valuations
Earnings
Shares outstanding
58.77M
Market cap
$1.45B
Enterprise value
$1.39B
Price to earnings (P/E)
N/A
Price to book (P/B)
5.43
Price to sales (P/S)
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.31
Revenue
$419.81M
Gross profit
$284.88M
Operating income
-$58.1M
Net income
-$58.53M
EBIT
-$55.81M
EBITDA
-$27.18M
Free cash flow
$8.29M
Per share
Balance sheet
Liquidity
EPS
-$1.02
EPS diluted
-$1.02
Free cash flow per share
$0.14
Book value per share
$4.56
Revenue per share
$7.29
TBVPS
$4.02
Total assets
$388.42M
Total liabilities
$123.61M
Debt
$17.8M
Equity
$264.81M
Working capital
$89.26M
Debt to equity
0.07
Current ratio
1.78
Quick ratio
1.38
Net debt/EBITDA
2.44
Margins
Efficiency
Dividend
EBITDA margin
-6.5%
Gross margin
67.9%
Net margin
-13.9%
Operating margin
-13.8%
Return on assets
-15.6%
Return on equity
-22.9%
Return on invested capital
-119.2%
Return on capital employed
-20.3%
Return on sales
-13.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PHR stock price
How has the Phreesia stock price performed over time
Intraday
0.65%
1 week
3.25%
1 month
-11.92%
1 year
20.97%
YTD
-1.63%
QTD
-3.17%
Financial performance
How have Phreesia's revenue and profit performed over time
Revenue
$419.81M
Gross profit
$284.88M
Operating income
-$58.1M
Net income
-$58.53M
Gross margin
67.9%
Net margin
-13.9%
The net margin has surged by 64% year-on-year and by 32% since the previous quarter
The operating margin has soared by 64% YoY and by 30% QoQ
The operating income has soared by 57% year-on-year and by 27% since the previous quarter
Phreesia's net income has soared by 57% YoY and by 29% from the previous quarter
Growth
What is Phreesia's growth rate over time
Valuation
What is Phreesia stock price valuation
P/E
N/A
P/B
5.43
P/S
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.31
PHR's EPS has surged by 59% year-on-year and by 30% since the previous quarter
PHR's P/B is 11% below its 5-year quarterly average of 6.1 but 4.4% above its last 4 quarters average of 5.2
Phreesia's equity has increased by 5% YoY and by 4% from the previous quarter
The P/S is 56% less than the 5-year quarterly average of 7.8 but 3% more than the last 4 quarters average of 3.3
Phreesia's revenue has increased by 18% YoY and by 3.6% QoQ
Efficiency
How efficient is Phreesia business performance
PHR's return on sales has surged by 65% year-on-year and by 34% since the previous quarter
Phreesia's return on invested capital has surged by 63% YoY and by 38% QoQ
The ROA has soared by 59% YoY and by 30% from the previous quarter
The return on equity has surged by 57% year-on-year and by 30% since the previous quarter
Dividends
What is PHR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PHR.
Financial health
How did Phreesia financials performed over time
The total assets has grown by 4.9% year-on-year and by 3.4% since the previous quarter
The total liabilities rose by 4% YoY and by 2.1% QoQ
The debt is 93% smaller than the equity
The debt is up by 49% year-on-year but it has declined by 15% since the previous quarter
PHR's debt to equity is up by 40% year-on-year but it is down by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.